BRDTP1

Across TCGA pan-cancer cohorts, BRDTP1 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated BRDTP1 data layer compared with 6 for mutation status.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher BRDTP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BRDTP1 expression acts as an unfavorable survival marker, although some lineages such as OV and LAML show a favorable association.

BLCA, OV, and STAD are the cancer types where BRDTP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.298	0.613	<.001	105	view →
OV	OS	Tertile	II,III,IV	0.763	0.666	.012	54	view →
STAD	OS	Tertile	All	0.195	0.419	.003	42	view →
THYM	OS	Tertile	All	0.352	0.884	<.001	24	view →
LAML	DFS	Median	All	0.558	0.396	.018	18	view →
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	18	view →
LUAD	DFS	Tertile	IV	0.671	0.893	.019	12	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	9	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
PRAD	DFS	Tertile	All	0.775	0.937	.032	6	view →
READ	DFS	Tertile	II,III,IV	1.000	0.775	.039	6	view →
LGG	DFS	Tertile	All	0.939	0.821	.037	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

BRDTP1–BLCA (OS)

Open the BLCA breakdown →